News | News By Subject | News by Disease News By Date | Search News

Leukemia News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bernie Sanders Demands Info on Ariad (ARIA)'s Leukemia Drug     10/24/2016
FDA Berates Celator Pharma (CPXX) for Pushing Unapproved Leukemia Drug to Doctors     9/8/2016
KaloBios (KBIO) Fires Martin Shkreli, UC Davis Suspends Leukemia Trial Due to Shkreli     12/23/2015
Poland’s Selvita Stakes Out its Own Space in U.S. Pharma Hubs of Boston and San Francisco     9/18/2015
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones     9/16/2015
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever     8/4/2015
FDA OKs Juno (JUNO)'s IND for Lead Leukemia Candidate JCAR015     8/3/2015
Amgen (AMGN) Lauds Positive Phase II Data for Leukemia Drug Blincyto     7/17/2015
Baxter International (BAX) Puts Down $900 Million to Beef Up Cancer Products for Spinoff     5/13/2015
AbbVie (ABBV), Genentech (RHHBY) Leukemia Drug Wins Breakthrough Status Tag     5/11/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst     3/6/2015
EXCLUSIVE: Experimental Cancer Drug From Oncoceutics Could Be Fast-Tracked, Says Exec     3/6/2015
Eagle Pharmaceuticals (EGRX), Teva Pharmaceutical Industries (TEVA) Forge $120 Million Leukemia Drug Pact     2/18/2015
Amgen (AMGN)'s Blincyto To Carry A Hefty $178,000 Price Tag     12/19/2014

News from Around the Web
A New Antibody For Treating Acute Lymphocytic Leukemia?     12/6/2016
Small-Molecule Tool Could Reduce Leukemia Cell Regeneration, University of California, San Diego (UCSD) Study     6/13/2016
Body's Own Gene Editing System Generates Leukemia Stem Cells, University of California San Diego School of Medicine Study Reveals     6/10/2016
Untested ‘Designer Cell’ Treatment Saved One Year Old From Leukemia, Great Ormond Street Hospital Reveals     4/11/2016
Main Ingredient Of Artificial Sweetener Splenda Linked To Leukemia, Study Published In International Journal Of Occupational And Environmental Health     3/14/2016
Umbilical Blood Cells Kill Cancer Quicker Than Adult Cells, Great Ormond Street Hospital For Children Study     2/8/2016
New Way For Early Detection Of Potentially Deadly Fungal Infection In Leukemia Patients Discovered, University of Texas Medical Branch at Galveston Researchers Reveal     12/15/2015
Designer Cells Cure One-Year Old Cancer Patient, Nature Reveals     11/6/2015
Avocados May Help Fight Blood Cancer, University Of Waterloo Study     6/17/2015
How Red Wine Prevents Cancer, University of Colorado Study     12/5/2014
New Drug May Be Effective Against Many Cancer Types, University College London Study     6/13/2014
Drugs To Watch: Potential Blockbusters Of 2014     4/17/2014
Mutations In Leukemia Gene Linked To New Childhood Growth Disorder, The Institute of Cancer Research Study     3/10/2014
Discovery of Novel Gene Mutations in Leukemia Patients Opens Up Personalized Therapy Options, Ludwig-Maximilians-University and Helmholtz Zentrum Munchen Study     8/5/2013
Drug Shows Surprising Efficacy as Treatment for Chronic Leukemia, Mantle Cell Lymphoma, Ohio State University Study     6/20/2013

Press Releases
Arvinas Collaborators Present Data On BET PROTAC Degraders At 2016 American Society of Hematology Annual Meeting     12/6/2016
AstraZeneca PLC (AZN) Release: Early Data Demonstrate Clinical Activity Of Acalabrutinib In Difficult-to-Treat Chronic Lymphocytic Leukemia     12/6/2016
AbbVie (ABBV) Release: IMBRUVICA (ibrutinib) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5-Year Analysis And Long-Term RESONATE-2 Follow-Up Data At American Society of Hematology 2016 Show Lasting Efficacy     12/5/2016
Children's Hospital of Philadelphia Release: In Clinical Trials, CAR T Cell Immunotherapy Continues To Yield Complete Responses In Children & Young Adults With Relapsed And Refractory Leukemia     12/5/2016
Synpromics Announces Collaboration With Sartorius Stedim Cellca To Develop Improved Biologicals Manufacturing Process Using Synthetic Promoters     12/5/2016
ERYtech Pharma Presents New Data On GRASPA’s Mechanism Of Action At American Society of Hematology Annual Meeting     12/1/2016
Teva (TEVA) Secures European Approval Of Trisenox For First Line Treatment Of Low To Intermediate Risk Acute Promyelocytic Leukemia (APL)     11/21/2016
Imago Biosciences Enrolls First Patient In Phase 1/2 Study Of IMG-7289 In Acute Myeloid Leukemia And Myelodysplastic Syndrome     11/9/2016
Salk Institute for Biological Studies Release: Heart Disease, Leukemia Linked To Dysfunction In Nucleus     11/4/2016
Nordic Nanovector And Heidelberg Pharma Enter Collaboration To Develop Novel Antibody-Drug Conjugates (ADCs) Targeting Leukaemias     10/26/2016
Cellerant Therapeutics, Inc. Presents Preclinical Data Showing Promise Of A Novel Differentiated Target On Leukemic Stem Cells     10/11/2016
Amgen (AMGN) Release: Study Results Published In Journal Of Clinical Oncology Show BLINCYTO (Blinatumomab) Induced Complete Remission In Heavily Pretreated Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia     10/4/2016
Eisai Company (ESALY.PK) Release: Anticancer Agent "Treakisym For Injection 100 Mg" Approved In Japan For Additional Indication Of Chronic Lymphocytic Leukemia     8/26/2016
Asuragen, Inc.'s QuantideX qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance For Monitoring Minimal Residual Disease In Chronic Myeloid Leukemia     7/25/2016
Celyad Successfully Completes Safety Follow-Up Of The First Patient At The Fourth Dose Level In The NKR-2 Phase I Trial     7/14/2016

//-->